Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Johnson & Johnson (

Idaho announces $119 million opioid crisis settlement

Idaho officials have announced a $119 million settlement with drugmaker Johnson & Johnson and three major distributors over their role in the opioid addiction crisis

The Independent UK

Ohio judge hears if pharmacy chains should pay for driving opioid crisis

Ohio judge hears if pharmacy chains should pay for driving opioid crisis

CVS, Walgreens and Walmart Were found to recklessly dispense narcotic painkillers in two Ohio counties, fueling a drug epidemic

The Guardian - US

400 million COVID-19 vaccine doses dumped by Baltimore plant, congressional report finds

BALTIMORE — The Maryland-based vaccine maker Emergent BioSolutions was forced to destroy nearly 400 million doses of COVID-19 vaccine because of potential contamination at its East Baltimore plant, far more than previously known.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

This Is What Whales Are Betting On Johnson & Johnson

A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 20 strange trades.

The Daily Biotech Pulse: Limited Use Of JNJ's COVID-19 Shot, Myovant-Pfizer's Relugolix Application Delayed, Gain Therapeutics' Parkinson's Data

Here's a roundup of top developments in the biotech space over the last 24 hours.

Morning Brief: Top Financial Stories Dominating on Friday, May 6

Reuters IHG Hotels & Resorts On Way To Recovery As Travel Booms

Johnson & Johnson Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 10 strange trades.

inkl

Read news from The Economist, FT, and more,
with one subscription

A lawsuit by survivors of the Tulsa Race Massacre can proceed, a judge rules

A lawsuit by survivors of the Tulsa Race Massacre can proceed, a judge rules

An Oklahoma judge has ruled that a lawsuit seeking reparations for the 1921 Tulsa Race Massacre can proceed, bringing new hope for justice for three centenarian survivors of the deadly racist attack.

Radical plans to transform NHS drawn up at drug firms and No 10 roundtable

Radical plans to transform NHS drawn up at drug firms and No 10 roundtable

Exclusive: ideas include reducing trial safeguards and allowing startups to harvest patient data

The Guardian - UK

Washington reaches $518M settlement with opioid distributors

Washington reaches $518M settlement with opioid distributors

Months into a complex trial over their role in flooding Washington with highly addictive painkillers, the nation’s three largest opioid distributors have agreed to pay the state $518 million

The Independent UK

Judge lets Tulsa Race Massacre reparations lawsuit proceed

Judge lets Tulsa Race Massacre reparations lawsuit proceed

An Oklahoma judge has ruled that a lawsuit can proceed that seeks reparations for survivors and descendants of victims of the 1921 Tulsa Race Massacre

The Independent UK

Johnson & Johnson shareholders called on to end talc baby powder sales

Johnson & Johnson shareholders called on to end talc baby powder sales

Resolutions to be voted on at shareholder meeting including stopping global sales of product and racial justice audit

The Guardian - US

Check Out What Whales Are Doing With JNJ

Check Out What Whales Are Doing With JNJ

Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Johnson & Johnson Whale Trades For April 20

Johnson & Johnson Whale Trades For April 20

A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 11 strange trades.

Get all your
news in one place.

100's of premium titles.
One news app.

Mid-Afternoon Market Update: Nasdaq Surges 200 Points; Dentsply Sirona Shares Plunge

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

Mid-Day Market Update: Crude Oil Down Over 5%; Checkmate Pharmaceuticals Shares Spike Higher

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

Mid-Morning Market Update: Markets Open Higher; Dow Jumps 400 Points

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 400 points on Tuesday.

What's Going On With Johnson & Johnson Stock?

Johnson & Johnson (NYSE: JNJ) shares are trading higher Tuesday after the company reported mixed financial results and increased its dividend.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

J&J suspends COVID-19 vaccine sales forecast

Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year

Johnson & Johnson Suspends Sales Forecast For COVID-19 Vaccine, Trims FY22 Profit Outlook

Johnson & Johnson (NYSE:JNJ) has reported Q1 FY22 adjusted earnings of $2.67 per share, up 3.1% Y/Y and ahead of the consensus of $2.61. Net sales increased 5% Y/Y (7.9% on an operational basis) to $23.43 billion, missing the consensus of $23.67 billion. Pharmaceuticals contributed $12.87 billion in sales, +9.3%, due to Darzalex…

Recap: Johnson & Johnson Q1 Earnings

Johnson & Johnson (NYSE:JNJ) reported its Q1 earnings results on Tuesday, April 19, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

The Independent UK

J&J's Janssen settles with WVa for $99M in opioid lawsuit

West Virginia will receive $99 million in a settlement finalized with Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. The state filed a lawsuit accusing the drugmaker of contributing to the opioid crisis in the state that's led the nation in overdose deaths

Earnings Outlook For Johnson & Johnson

Johnson & Johnson (NYSE:JNJ) is set to give its latest quarterly earnings report on Tuesday, 2022-04-19. Here's what investors need to know before the announcement. Analysts estimate that Johnson & Johnson will report an earnings per share (EPS) of $2.61.

5 Stocks to Buy for Stable Income in a Volatile Market

Because concerns over high inflation and increasing sanctions on Russia are expected to fuel stock market volatility in the near term, we think it could be wise to bet on dividend aristocrats Johnson & Johnson (JNJ), Procter & Gamble (PG), PepsiCo (PEP), Abbott (ABT), and Becton Dickinson (BDX) for a…

Forget AstraZeneca, Buy These 4 Pharmaceutical Stocks Instead

Despite the rising demand for COVID-19 vaccines and other pharmaceutical products, AstraZeneca (AZN) has failed to deliver impressive earnings in its last quarter. While its recent drug launches are expected to do well in the long run, the consensus earnings estimate for the company in the current quarter indicates tepid…

1 … 15 16 17 18

People

202,811 stories

Patrick Morrisey

Christian Klein

Carolyn B Maloney

Lessie Benningfield Randle

Damario SolomonSimmons

Lawrence Wasden

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Wikimedia Commons

Wall Street Journal

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

398,548 stories

Washington D.C.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play